mend
gluc
▁reac
ocyt
tained
▁endot
ureus
sial
▁progression
▁preservation
▁regar
▁aureus
▁basal
.8%
oplastic
▁cardiac
▁pathologic
osomes
▁mice
▁multic
emia
coh
▁abdominal
▁collec
▁possi
▁underg
▁phag
▁Addition
▁scanning
mediated
▁utilization
▁transcription
▁effec
▁rati
terminal
▁pulmonary
▁2
ucle
▁monoclonal
olism
omical
▁cohort
▁injec
▁combin
bic
▁prevalence
▁irradi
odynamic
▁deterior
▁anomal
duced
▁sperm
idated
athy
▁melan
▁endothelial
cine
▁spati
▁(7
onin
hea
▁prolonged
▁suppres
▁Neu
estion
ronch
ondr
▁histological
▁lipid
veolar
▁deterioration
▁GFR
▁polym
tec
thyl
▁Whereas
▁ultras
▁endothelin
▁microscop
urrent
▁symptom
▁carriers
▁adverse
5,
eared
▁kidney
vely
.8
▁11
▁12
▁adminis
leu
6%
entif
▁somatic
▁monitored
oglyc
▁proliferation
▁homogeneous
▁glomer
▁transi
▁coh
▁esophageal
versity
HB
▁serum
▁disapp
▁polymorph
▁Lys
esic
ociated
-7
plantation
eces
▁defic
▁coronary
▁molec
ilical
▁0.4
▁challen
▁embryo
▁locus
lobin
▁obser
▁Mg
iol
▁expres
▁1
imin
▁correlations
▁cystic
▁identif
56
▁8.
▁fibers
ochem
▁selectively
0%
▁stu
tens
▁inflammatory
ymp
vity
▁ablation
▁drin
reased
29
oplas
▁fetus
▁gradi
▁bronch
▁biopsy
gland
57
▁epithelial
▁supplementation
▁receptor
▁organisms
▁effic
2%)
crip
▁6
▁physiological
onucle
▁studi
yro
▁thromb
▁chromat
▁4-
▁inadequ
tics
itamin
▁excretion
▁sph
▁80
atitis
eric
mL
▁(3
olesterol
▁Tran
4.
▁manifestations
▁symp
▁corne
▁40%
▁tracer
-8
tural
▁amino
▁recurrence
tus
▁rats
▁16
▁28
▁intake
▁enzym
▁7.
mented
▁acids
▁angiography
▁shorten
lix
▁bir
vice
▁Hb
▁exogenous
EG
▁[3
▁subtype
▁mono
grees
▁ane
glut
▁longitudinal
▁mann
hyd
tures
asal
48
▁soy
phrine
▁27
▁infec
phic
▁Hg
uting
osomal
▁14
hydroxy
▁onset
▁previ
echn
lys
▁10(
MV
▁mRNA
▁targe
▁graf
▁cardi
aryngeal
ensory
▁HM
▁macropha
tality
mia
rates
▁carcin
▁adren
▁occupational
orectal
▁follic
▁prospectively
ejun
rele
00
0-
▁concom
▁cann
ometr
bac
▁chlor
▁differenti
▁epit
TG
▁antigen
▁implic
ergency
▁resusc
vul
▁kerat
▁unilateral
▁bronchial
▁catheters
risk
▁200
▁renal
▁restric
▁eosin
▁bloc
▁residues
▁vaginal
▁surgically
▁inversely
ullary
▁correlates
tif
▁allo
▁polymorphism
▁immature
▁prol
lobulin
esthe
▁somatostatin
▁unrelated
Pa
▁complexes
luent
eptides
6,
▁lys
treated
ophil
ximum
▁undergo
▁cancers
▁supple
opathy
ffin
ialysis
▁erg
▁amyloid
▁cyst
▁125
TNF
▁acqui
▁ischemic
▁potenti
ineal
▁Clinical
omat
▁panc
▁transfusion
gia
tic
▁rabbit
▁32
▁15
chol
lysis
ficial
▁100%
▁ACE
▁ultrasound
▁IA
eration
▁impairment
▁cerv
cardi
▁acute
▁infants
▁systolic
5%
▁prophyl
erin
▁contamin
erb
▁variability
alian
▁scre
aneously
▁toxicity
▁acidosis
▁severity
▁AMP
▁amo
ectomy
gic
pendent
▁provid
plas
▁alveolar
▁defec
stim
▁sple
▁tumors
▁cumulative
20
ophilic
acr
▁2.
▁tumours
▁skeletal
tabl
▁uncom
▁autoimmune
▁4
natal
▁85%
▁alk
.3
▁30
entanyl
phosph
odon
▁Doppler
▁lar
▁13
▁investigations
-1,
▁vesic
nai
▁cereb
ilic
▁adenocarcinoma
phosphate
▁0.0
positive
▁Hyp
▁multiv
▁putative
▁inhibit
itic
▁pharmac
▁Increased
itone
lux
lastic
▁systemic
▁ovarian
ocaine
▁extracellular
27
▁33
-3
tral
etal
▁ow
ept
▁phosphor
ults
▁monit
▁nM
▁57
▁smo
certain
ocular
44
▁immun
crib
▁asthma
▁colorectal
40
lyc
▁labeling
▁retrospective
▁adjustment
▁disappearance
▁glomerular
50
tinu
trib
urine
▁NH
roxim
▁statis
▁resonance
otor
▁vascular
onium
▁peri
▁imaging
ATP
▁iso
▁connective
clo
▁RP
versely
bral
9%
Phe
▁thi
asic
▁operative
rocy
▁tib
▁resection
erance
oclonal
▁discharge
itro
▁indicators
▁7
idation
ospor
▁pituitary
▁agon
▁reflec
▁poten
▁neurological
▁differing
▁enl
▁pancreatic
enic
▁analyses
▁anesthe
▁collateral
75
▁elucidate
atoid
▁2.5
▁complementary
lact
▁spon
▁500
▁reductions
▁irradiated
▁stimulation
taken
odies
▁immunological
22
▁gradients
▁cAMP
▁endometr
centr
operatively
▁insulin
atient
▁benign
▁transient
▁tric
went
▁sten
▁kidne
▁distal
lyce
▁diagnoses
▁26
▁repro
ylate
.9
▁complication
▁phospholip
monary
heal
ographically
/-
▁85
oic
▁progres
▁endoscop
utions
tel
▁mitochondr
▁MHC
▁leuk
▁discrimin
echan
invasive
genic
▁comparisons
oidal
ochrome
uted
osin
▁isch
▁obesity
65
▁compartment
ogens
▁tas
urgical
▁proce
▁2,
▁bowel
oplasmic
▁glands
▁dete
estig
▁transplantation
▁preven
vents
▁antic
21
▁diabetic
▁50
▁respiratory
inic
▁selec
tact
▁LD
▁arter
▁7%
0.5
▁mucosa
▁biopsies
▁LV
ithi
▁metastases
lood
▁markers
▁tryp
onc
▁inhibitors
▁IGF
▁21
▁40
▁0.2
pir
▁neurop
ventricular
▁predicting
▁Taken
urys
▁hemodialysis
▁CMV
▁questionnai
▁onc
▁pH
▁chemotactic
unctions
▁Increas
▁Serum
olip
▁Bec
▁melatonin
▁septum
idate
orption
▁aorta
▁recor
terone
pine
▁chloro
▁homogeneity
▁neon
OH
▁0
▁DF
imens
▁rectal
▁relap
▁pregnancies
trol
gative
▁trac
▁LC
▁assessing
▁kinase
▁contex
tivity
astom
▁distin
▁gland
essel
romes
tero
▁positively
▁ganglion
▁induction
▁metastasis
▁abnormalities
▁establ
onate
▁correlate
▁intensive
▁overlapping
▁phe
▁statistically
▁prophylaxis
othelial
▁anat
▁differentiate
▁chan
agic
▁preparations
▁thyroid
crimin
.7
4-
▁ischemia
ration
tory
▁umb
▁allergic
esity
till
tur
urther
mol
onyl
▁ile
▁rhe
▁cytos
▁correlated
▁antibiotic
▁purified
fos
iary
▁nec
atid
▁10
otomy
7.
▁compounds
▁conduc
▁contral
▁elic
▁34
▁3
▁eluc
▁membrane
mittent
▁numb
▁stimul
▁9
entan
▁GH
ochemistry
siological
▁follicle
▁rheumatoid
▁oxide
▁exis
▁tumor
▁progn
▁HLA
▁dilated
▁strains
activation
seud
▁perfusion
-4
▁antagon
▁airway
▁recurrent
▁examinations
▁facilit
osom
Tc
tors
▁sti
▁cen
▁hepar
▁elevation
▁0.05).
▁tox
▁melanoma
rine
2)
▁pneumon
▁depres
prising
otox
▁ischem
▁behavioral
▁0.6
▁plaque
▁theore
▁synovial
roximately
▁(0.
▁implant
▁phy
▁practic
10
1).
▁heparin
odal
rophy
▁quantit
▁urinary
▁scin
▁canc
▁lesion
▁judged
▁PB
iliac
▁infarction
▁catheter
idase
▁deli
▁opioid
ilization
▁lipoprotein
▁glycoprotein
▁tomography
▁synergistic
▁synerg
ompan
▁peptide
▁porcine
▁hep
▁prostatic
▁satur
▁limb
▁repor
▁maternal
▁contrac
▁vesicles
clerosis
tectable
▁segmental
tured
ellular
▁48
trop
▁nucleus
▁reagents
▁chemot
tension
oxid
owever
▁mutant
atase
oag
sions
▁ratios
▁concomitant
aturation
▁doses
60
arate
▁familial
▁31
▁comparative
ochondr
tration
▁lobe
osts
icin
-5
▁NP
▁perc
xia
din
bladder
DH
▁usefulness
▁sensi
▁Compared
▁inh
uble
▁synthesis
▁histologic
▁opi
sies
apeutic
▁deficits
tent
bly
85
▁hypoxia
itus
▁phosph
sive
monstr
ropine
omotor
▁ultim
▁perox
▁valve
gment
atonin
▁evoked
▁pate
▁biop
ximal
dle
▁insufficiency
▁metabol
▁pyramidal
▁overe
▁epinephrine
▁injections
minis
9,
dia
▁acet
radi
▁cholesterol
BV
▁reag
athyroid
▁intra
ostatin
19
▁pathway
loid
▁stimuli
5.
▁thre
5-
▁advan
▁confir
▁chor
▁etiology
yroid
▁salivary
▁predominantly
▁mitral
2%
regulation
▁stimulated
ropha
▁pressures
▁reper
▁TA
▁exchan
18
▁neutrophil
▁assays
athe
▁satis
▁myocardi
▁lymphocytes
▁nonc
ivation
glyc
▁hypoth
3)
▁infil
▁haem
▁elec
▁ach
namic
▁hypothe
▁nal
▁definite
▁pall
▁embry
▁emerg
▁sequential
antial
▁ventric
▁susceptibility
▁25
DG
▁mell
onography
sensitive
▁occurrence
utaneous
▁gangl
osome
▁excre
terol
▁turnover
▁indications
▁nutritional
▁bladder
-2
▁scans
▁0.3
5)
▁compart
▁silic
rents
▁specificity
▁1,
▁macrophages
atine
uncture
▁abnormal
▁pathogenesis
sible
▁infiltration
▁microgram
1-
bacco
▁reflecting
▁cyt
▁phenotype
▁ure
▁5-
oradi
▁(2
▁15%
8,
▁ventilation
▁olig
▁carcinoma
▁shif
▁hepatocytes
apeu
hydrox
▁incidence
▁morb
▁swelling
▁tumour
▁pathological
▁3.
▁propor
▁excision
▁5.
▁retention
ffinity
illary
▁physicians
▁detectable
▁ovari
tive
▁accumulation
tries
▁preferen
1.
▁uter
ochemical
▁regis
▁transcrip
▁premature
▁ket
▁markedly
▁rabb
mature
25
▁receptors
▁diminished
▁carotid
▁vein
lym
▁unex
lob
quine
rox
.1
▁substances
astric
▁discus
helin
31
▁Treatment
▁mortality
▁inflammation
▁remission
▁pancre
renal
▁deficit
▁atherosclerosis
▁oxid
NB
▁sampl
▁HC
▁efficacy
0,
rehen
.2
helial
▁physici
6)
gely
nthe
ergy
▁hepatitis
spectively
uscular
erative
▁toge
▁Tum
▁vitro
▁cortex
▁collagen
▁thym
▁differen
%),
phen
▁preoperative
▁alcoh
▁subjected
▁postoperatively
jected
▁exer
▁oste
▁MV
ylated
▁anastomosis
rectomy
▁impair
▁hetero
▁membran
▁superficial
▁ventricular
▁hepatic
▁schiz
▁17
▁retin
▁randomized
▁hypertensive
▁chromatography
NH
tum
▁0.05
▁cardiomy
▁saturated
▁plasm
▁fetal
taining
▁follicular
trac
gene
▁increas
tance
tric
▁37
▁morphologic
osterone
adder
▁IgM
▁confined
immune
associated
▁memb
▁subgroup
▁tes
▁cerebral
erad
▁MRI
▁herpes
▁seizures
%).
▁heterogene
atest
duce
▁morphology
▁99
▁adop
▁cellular
▁agonist
tively
▁inflamm
ocardial
ycin
acet
▁dietary
▁hypog
▁ae
▁demonstrates
▁affec
▁fas
▁deficiency
▁malign
▁Asp
▁compartments
▁0.00
000
ocytes
omal
▁remo
▁decreas
▁0.
▁29
▁preliminary
oplasm
▁ana
Ca
▁plas
▁(4
entical
▁aneurysm
tig
▁0.7
adily
▁unstable
aryn
▁chol
itin
lymph
▁subjec
avage
eak
tabol
1,
2,
▁arthritis
aturated
▁substantially
occus
▁clus
▁Chan
▁metastatic
▁BP
7%
entral
▁ulcer
▁amp
osine
asone
12
▁19
▁pineal
otide
cessive
tak
▁degrad
▁electroph
▁zinc
odialysis
▁5
▁pancreatitis
omized
▁graft
▁eryth
zard
▁spontaneous
▁nig
7,
▁enzymes
▁differe
▁alteration
13
16
ariate
ontal
▁requi
▁summ
▁anastom
rosis
controlled
▁kDa
▁electr
▁Comparison
cious
53
▁deprivation
▁chemotherapy
35
▁hypers
▁Afric
▁carbohyd
▁assessed
▁fracture
atif
▁resul
ogenesis
▁hypoxic
▁bovine
ypical
dition
ocyte
▁neurologic
coun
▁intram
clin
▁molecules
▁influenz
▁drainage
alc
▁secretion
aptic
▁differentiated
▁aortic
▁fluores
iminary
osal
▁foc
vation
▁persis
tead
ocl
2.
▁prostate
sess
▁implicated
irc
▁surgical
▁sacr
▁79
▁traum
▁injected
viron
▁diffic
odium
lasts
▁adenomas
minal
▁phosphate
onomic
▁fixation
▁influenza
▁placebo
▁thrombo
▁prospective
mentation
rogenic
▁throm
▁simultaneous
99
▁localized
▁8
▁promo
▁beha
▁antibodies
▁moderately
sych
.5
▁thresholds
▁hemodynamics
▁atrophy
▁ambulatory
▁stren
▁characterize
▁HSV
oplasty
▁lumbar
▁pati
▁intest
▁(19
2).
▁chec
▁endometrial
ilized
▁umbilical
acil
▁cultured
▁therapeutic
intestinal
scop
▁phosphorylation
▁endogenous
▁infections
▁bypass
▁sero
operative
▁glut
▁PF
▁measurable
4).
▁demonstrating
▁lateral
▁obese
▁cyclic
▁197
ogenic
▁induc
▁prognostic
▁proportional
▁undergone
▁athe
armac
▁36
▁depr
▁fatigue
▁hazard
▁nodules
▁chond
▁regimen
▁adherence
3,
▁discon
▁repres
▁radiotherapy
▁(9
ilateral
▁postoperative
tially
▁pyl
▁inactiv
▁TC
▁molecule
ovine
idine
ignific
ociation
▁femoral
▁tris
▁criter
▁kine
igaret
▁cephal
▁vaccin
▁rhy
tin
▁lumb
ortic
EGF
fec
▁35
▁testis
anine
stimulated
▁hormonal
atment
▁assis
illus
▁microv
▁antagonist
▁saline
regulated
▁conclu
labeled
▁responsiveness
▁elimination
MN
▁echocardi
adic
lip
▁polyp
▁Pretreatment
▁complications
▁reperfusion
nec
30
ectom
▁distrib
▁undergoing
▁cardiomyopathy
▁mutations
tensive
rene
▁multivariate
onary
▁cDNA
qui
▁exce
▁parental
tro
▁urine
▁detec
ceptive
keletal
▁insertion
ograms
lec
▁regulate
49
▁homogene
▁tissues
atories
▁intrinsic
▁sugges
▁PV
▁mediated
tically
ituitary
teroid
▁diame
▁incubation
2+
▁predictive
iasis
▁indi
▁RBC
▁postnatal
ensi
occal
▁muc
▁0.05)
▁incub
vic
ovascular
▁screened
ameth
▁GV
79
tiv
-6
▁hypertension
▁unclear
▁Patients
ighted
▁subgroups
quid
tial
jug
▁exhibited
itant
unctional
▁LDL
phal
immun
▁fibrob
▁platelet
▁inadequate
oracic
▁neutroph
▁bene
olol
▁respec
treatment
▁hypo
▁subunit
fected
▁macrophage
cence
▁(8
▁normo
▁implantation
feren
▁Cyt
RH
▁22
▁lact
opausal
resting
▁lipids
thma
tional
▁extrac
▁stenosis
opamine
▁shor
▁creatine
▁hormone
▁perin
venous
ogenous
▁limbs
ocar
stolic
tase
▁pediatric
cribed
▁acco
▁ethanol
▁micron
▁consis
8.
sia
11
▁cocaine
▁LH
▁specimens
yel
▁pneumonia
mide
▁(1
▁staining
▁enhancing
▁ventilatory
▁contralateral
kele
▁1.
reast
▁leakage
.2%
▁morbidity
▁cutaneous
▁quantitative
▁recombin
▁underst
32
tized
▁PCR
amide
occi
▁congen
methyl
▁quanti
tomy
▁viral
▁20
▁anemia
▁synov
ylase
ogra
28
2-
▁prenatal
▁malignant
tage
aline
▁pathology
▁substitution
'-
tation
▁micrograms
tis
▁gluc
ergic
▁latency
▁heterogeneous
▁hemodynamic
▁sensory
▁75
-9
-1
▁membranes
▁administered
▁intrac
derly
▁0.5
piratory
induced
▁relapse
▁concurrent
15
bility
2/
▁thoracic
▁inver
urea
▁interv
▁substrate
adren
▁latent
34
▁selective
3-
rophob
▁edema
▁Intra
ophren
▁experim
▁atropine
▁TG
▁tolerated
▁anatomical
otyp
▁produc
▁vitamin
▁antibody
▁Ig
orpor
Ig
▁wee
80
anding
6.
▁comple
▁coli
▁cervical
▁+/-
▁cytotox
iably
▁congenital
▁metabolic
tions
▁compli
▁CK
▁ery
hemical
▁intraven
▁cate
▁symptomatic
▁hepat
▁lymph
ctomy
icine
▁intracellular
ethyl
▁45
kely
epti
▁undertaken
▁venous
▁(6
▁antigens
▁fati
ologic
▁affinity
▁periodontal
ylcholine
▁tran
▁adequ
/2
▁ATP
tual
esti
▁characteris
▁adhe
jun
▁pelvic
acting
▁contrib
▁interc
▁IU
▁peptides
▁esophag
▁enti
▁intrap
▁estrogen
orrh
▁aor
iatric
▁abnormality
▁determinants
ocytic
DNA
▁physiologic
rease
▁oes
▁vaccination
▁immunore
▁favorable
▁1.6
▁marrow
▁glucose
loro
duction
▁stimulate
▁elevated
▁extre
piration
▁valu
▁microM
▁hemorrh
▁CI
ture
▁recom
▁vivo
ygen
▁adjuvant
truc
angl
lusion
▁dosing
▁cortisol
▁parame
bumin
▁spinal
orac
▁contributes
▁myocardial
▁techniqu
▁regimens
▁leukocyte
▁benz
▁mL
▁testicular
gth
▁infar
▁sepsis
▁hypot
▁inhibitory
fusion
▁24
▁reduc
ritis
ophag
▁(10
▁PCO
4,
▁strom
▁uptake
otrop
▁potency
adequ
▁encoun
aemia
▁exten
▁unde
▁corneal
otropic
▁18
spective
estions
▁enzyme
sion
▁trig
▁pla
acted
▁50%
▁impaired
▁lith
▁angi
▁metabolism
lated
▁0.9
▁amyl
▁invasive
▁1-
▁1.7
▁23
▁reas
▁fatty
▁arth
ocardi
▁examin
▁anticoag
ylation
▁bilateral
▁placenta
70
▁ECG
idne
olated
▁tiss
toc
▁predic
▁prel
▁neph
▁hyperg
ditions
▁hCG
▁neurons
▁150
owel
▁variants
-10
▁HL
▁cathe
0.
▁sci
oscopy
▁artery
▁elu
▁dexamethasone
▁inhibitor
▁chloride
▁10-
▁potent
.0
▁reagent
erated
▁aerobic
▁assay
anol
▁ventil
▁2-
▁decreasing
▁disruption
▁3-
oscop
oxic
▁dissection
▁clon
▁inhibited
hep
▁arteries
helium
▁100
▁sulf
vascular
▁Significant
oprotein
jec
▁aden
▁glyc
▁reflux
▁prognosis
▁simult
▁indicative
hern
▁displacement
▁undetectable
▁neonatal
opro
▁reproducible
estis
▁dysfunction
tical
▁TGF
ulatory
▁RA
▁verte
▁cigaret
▁decreased
▁heterogeneity
1)
▁vagal
ffec
▁elimin
▁nasal
usp
▁differentiation
▁struc
mTc
▁bac
▁thir
▁mellitus
.6
▁mM
▁infusion
▁injur
▁intrav
4)
▁IgG
▁attrib
▁modulate
▁pyram
▁synthe
▁evaluating
pH
▁dehyd
▁polymer
tein
▁myel
▁lesions
▁intravenous
▁(5
▁VO
ints
▁calcium
ropriate
iotic
▁sodium
▁gamma
▁mucosal
▁evid
▁peripheral
▁induce
▁reproduc
▁RNA
▁Acute
▁HPV
▁saliv
dominal
▁concentrations
▁hypox
▁proteins
tion
menopausal
1),
▁medial
ministration
inemia
eded
eptide
▁inhibition
▁198
14
▁necrosis
▁avail
titu
▁fractions
▁immunode
▁fractures
uvant
sities
LV
oprote
▁subc
▁cardiovascular
RNA
roph
▁pharmacological
▁exposures
▁intramuscular
▁bip
▁restor
aemic
▁atheros
opa
▁gastric
oride
▁0.1
ctive
▁prolif
/1
ylchol
asive
▁cyclosporine
▁atten
▁amin
▁psychiatric
erate
ostic
▁arterial
▁intermittent
▁diabe
geal
▁somat
▁atrial
atients
erating
▁metast
▁substituted
▁60
dose
dial
ayed
reas
▁oxy
▁molar
▁pneum
mental
▁sexes
▁0.8
▁suppression
▁percutaneous
8%
▁perip
▁subun
▁clinically
▁dex
.4
▁auditory
▁inten
olysis
▁alterations
